We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$159M
(-1.2%)
Cap. Flow
+$1.08B
Cap. Flow
% of AUM
8.52%
Top 10 Holdings %
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$63.1M |
| 2 |
WW
WW International
WW
|
+$57.1M |
| 3 |
Hexcel
HXL
|
+$57.1M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$54.4M |
| 5 |
HealthEquity
HQY
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$70.3M |
| 2 |
WCN
Waste Connections
WCN
|
+$61.3M |
| 3 |
Acuity Brands
AYI
|
+$56.2M |
| 4 |
JetBlue
JBLU
|
+$54.3M |
| 5 |
Martin Marietta Materials
MLM
|
+$53.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.28% |
| 2 | Technology | 18.45% |
| 3 | Industrials | 14.15% |
| 4 | Consumer Discretionary | 14.07% |
| 5 | Financials | 10.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Global Payments
GPN
$24.1B
| $2.45M | 0.02% |
+22,000
| New | +$2.49M |
|
427
Biogen
BIIB
$30.9B
| $2.41M | 0.02% |
+8,300
| New | +$2.33M |
|
428
Lindblad Expeditions
LIND
$1.95B
| $2.33M | 0.02% |
175,975
+10,125
| +6% | +$120K |
|
429
Applied Materials
AMAT
$347B
| $2.29M | 0.02% |
+49,700
| New | +$2.56M |
|
430
State Street
STT
$48.4B
| $2.29M | 0.02% |
+24,600
| New | +$2.44M |
|
431
Wyndham Hotels & Resorts
WH
$5.61B
| $2.28M | 0.02% |
+38,700
| New | +$2.38M |
|
|
IPHI
432
DELISTED
INPHI CORPORATION
IPHI
| $2.19M | 0.02% |
67,215
-985
| -1% | -$32.2K |
|
|
CELG
433
DELISTED
Celgene Corp
CELG
| $2.19M | 0.02% |
+27,600
| New | +$2.29M |
|
434
CareTrust REIT
CTRE
$10B
| $2.19M | 0.02% |
130,985
-340
| -0.3% | -$5.11K |
|
435
General Dynamics
GD
$103B
| $2.18M | 0.02% |
+11,700
| New | +$2.4M |
|
436
Bank of America
BAC
$429B
| $2.17M | 0.02% |
+77,000
| New | +$2.3M |
|
437
Zions Bancorporation
ZION
$10.1B
| $2.17M | 0.02% |
41,100
-46,721
| -53% | -$2.58M |
|
438
Plexus
PLXS
$6.43B
| $1.93M | 0.02% |
32,395
-30
| -0.1% | -$1.79K |
|
439
Impinj
PI
$4.24B
| $1.88M | 0.01% |
85,161
-164
| -0.2% | -$2.78K |
|
440
Carpenter Technology
CRS
$26.4B
| $1.87M | 0.01% |
35,642
-508
| -1% | -$27.5K |
|
|
QTS
441
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.76M | 0.01% |
44,602
+27
| +0.1% | +$997 |
|
442
Westlake Corp
WLK
$9.26B
| $1.74M | 0.01% |
16,165
-127,985
| -89% | -$14.3M |
|
443
Travel + Leisure Co
TNL
$4.76B
| $1.73M | 0.01% |
39,000
-28,287
| -42% | -$1.4M |
|
444
CVS Health
CVS
$135B
| $1.72M | 0.01% |
+26,800
| New | +$1.77M |
|
445
O-I Glass
OI
$1.18B
| $1.72M | 0.01% |
+102,300
| New | +$1.98M |
|
446
Amneal Pharmaceuticals
AMRX
$6.1B
| $1.66M | 0.01% |
+101,108
| New | +$1.77M |
|
447
Stanley Black & Decker
SWK
$14.5B
| $1.59M | 0.01% |
+12,000
| New | +$1.73M |
|
448
LiveRamp
RAMP
$2.29B
| $1.42M | 0.01% |
47,470
-1,730
| -4% | -$47.4K |
|
|
GPOR
449
DELISTED
Gulfport Energy Corp.
GPOR
| $1.32M | 0.01% |
105,253
-1,822
| -2% | -$18.8K |
|
450
Radiant Logistics
RLGT
$400M
| $1.24M | 0.01% |
316,250
+17,550
| +6% | +$68.6K |
|
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.
- Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
- Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
- Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
- Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
- Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
- Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
- Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.
Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.